|
Effects of betahistine on the vestibular receptors: binding sites
|
|
|
Effects of long-term benzodiazepine use
|
|
|
Diacerein : A New Symptomatic Slow Acting Drug for Osteoarthritis
|
|
|
Febuxostat: A Novel Non-Purine Selective Inhibitor of Xanthine Oxidase for the Treatment of Hyperuricemia in Gout
|
|
|
Itopride : A Novel Prokinetic Agent
|
|
|
Drug release kinetics from matrix combining mixture of hydrophilic and hydrophobic polymers on Mebeverine HCL, on site specific drug release to the colon
|
|
|
Sodium picosulfate in opioid-induced constipation: results of an open-label, prospective, dose-ranging study
|
|
|
Review on Various Approaches to Treat Irritable Bowel Syndrome and Superiority of Combinations Over the Existing Therapy
|
|
|
Results of a randomized, lactulose-controlled study
|
|
|
Escitalopram for the treatment of major depression and anxiety disorders
|
|
|
Research article The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
|
|
|
RA Novel Non-Purine Selective Inhibitor of Xanthine Oxidase for the Treatment of Hyperuricemia in Gout
|
|
|
A randomized controlled cross-over study of flupenthixol + melitracen in functional dyspepsia
|
|
|
Influence of irritable bowel syndrome on treatment outcome in gastroesophageal reflux disease
|
|
Mission Research Lab
Mission Research Laboratories